30
Participants
Start Date
December 20, 2013
Primary Completion Date
September 23, 2016
Study Completion Date
September 23, 2016
PEGylated Recombinant factor VIII (rFVIII)
Lyophilized powder and solvent for solution for injection
SHAT of Oncohaematology Diseases, Sofia
Universitaetsspital Zuerich, Zurich
MHAT 'Sv. Marina', EAD, Varna
Complejo Hospitalario Universitario A Coruña, A Coruña
Penn State Milton S. Hershey Medical Center, Hershey
Hospital Regional Universitario de Malaga, Málaga
University of Florida College of Medicine, Gainesville
University of Louisville, Louisville
Cincinnati Children's Hospital Medical Center, Cincinnati
Hospital Universitari i Politecnic La Fe, Valencia
Bleeding and Clotting Disorders Institute, Peoria
Children's Mercy Hospitals & Clinics, Kansas City
SI Institute of Blood Pathology and Transfusion Medicine of AMSU, Lviv
University of Utah Health Sciences Center, Salt Lake City
University of Washington, Seattle
"FSHI Kirov SR Institute of Hematology and Blood Transfusion FMBA", Kirov
Vilnius University Hospital Santariskiu Clinics, Public Institution, Vilnius
Academisch Medisch Centrum, Amsterdam
Hospital Universitari Son Espases, Palma de Mallorca
Royal Free Hospital, London
Great Ormond Street Hospital for Children, London
Royal Manchester Children's Hospital, Manchester
Baxalta now part of Shire
INDUSTRY